Keros Therapeutics Inc. (KROS)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 64
+0.03
+0.2828%
$
338.22M Market Cap
- P/E Ratio
- Div Yield
142,800 Volume
-5.27 Eps
$ 10.61
Previous Close 
Want to track KROS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Keros Therapeutics Inc. (KROS) Statistics
Valuation metrics
Market Cap 338.22M
Enterprise value 75.27M
Trailing P/E (ttm) -4.36
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 10.26
Price/Book (mrq) 1.39
Enterprise Value/Revenue 2.27
Enterprise Value/EBITDA -0.85
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 139.64K
Average volume (90 days) 353.67K
Price summary
52-Week low 9.69
52-Week high 22.55
Beta -
50-Day moving average 10.61
200-Day moving average 13.81
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.57%
Operating margin -3.33%
Operational effectiveness
Return on assets -0.27%
Return on equity -0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.89
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 22.62%
Book value per share (mrq) 7.67
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
